Aims and scope of journal
The European Journal of Human Genetics is the official journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports and reviews in the rapidly expanding field of human genetics and genomics. It covers molecular, clinical and cytogenetics, interfacing between advanced biomedical research and the clinician, and bridging the great diversity of facilities, resources and viewpoints in the genetics community.
Key areas include:
- Monogenic and multifactorial disorders
- Development and malformation
- Hereditary cancer
- Medical Genomics
- Gene mapping and functional studies
- Genotype-phenotype correlations
- Genetic variation and genome diversity
- Statistical and computational genetics
- Advances in diagnostics
- Therapy and prevention
- Animal models
- Genetic services
- Community genetics
The journal also publishes invited editorials and commentaries, announcements of societal and other European activities and special issues of general interest for the human genetics community.
The European Journal of Human Genetics covers a range of subject areas, to read content across the scope of the journal view the journal's subjects page here.
12 issues per year
Our publishing models
European Journal of Human Genetics is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
European Journal of Human Genetics is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2020 peer review performance metrics for European Journal of Human Genetics are shown below:
Average time to decision without external review - 9 days
Average time to decision following external review - 79 days
Average time from submission to acceptance - 173 days
Average time from acceptance to publication - 16 days
Article page views - 1,635,519
Altmetric mentions - 5,054
The 2020 journal metrics for European Journal of Human Genetics are as follows:
2-year Impact Factor*: 4.246
5-year Impact Factor*: 4.440
Immediacy index*: 1.525
Eigenfactor® score*: 0.01788
Article influence score*: 1.555
JCR Rank*: 60/175 Genetics & Heredity; 126/298 Biochemistry & Molecular Biology
Journal Cotation Score*: 0.91
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2021)
EBSCO Discovery Service
Summon by ProQuest
Current Contents/Life Sciences
Science Citation Index
Science Citation Index Expanded (SciSearch)
EBSCO Academic Search
EBSCO Advanced Placement Source
EBSCO Biomedical Reference Collection
EBSCO Consumer Health Complete
EBSCO STM Source
EBSCO Health Source: Nursing/Academic Edition
EBSCO TOC Premier
ISSN and eISSN
International standard serial number (ISSN): 1018-4813
Electronic international standard serial number (eISSN): 1476-5438
European Journal of Human Genetics now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.